Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa Study of Recombinant ESAT6-CFP10 Antigen
NCT02329730Phase 2Completed
- Sponsor
- Zhifei Biological
- Start
- Feb 2014
- Primary completion
- Jun 2014
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
01
Overview
Phase 2, randomised trial of C-Tb in Tuberculosis (TB) (3 arms), sponsored by Zhifei Biological. Primary endpoints: Number of Participants with Reaction at 24 Hours, Number of Participants with Reaction at 48 Hours and 2 more. Started Feb 2014; status: completed.
02
Drugs
C-Tb
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT02329730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02329730.